scholarly article | Q13442814 |
P356 | DOI | 10.1152/AJPGI.00200.2006 |
P698 | PubMed publication ID | 16959952 |
P2093 | author name string | Anping Chen | |
Shizhong Zheng | |||
P2860 | cites work | Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element | Q24629916 |
Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling | Q27765346 | ||
The organization, promoter analysis, and expression of the human PPARgamma gene | Q28244071 | ||
Human Smad3 and Smad4 are sequence-specific transcription activators | Q28276193 | ||
Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization | Q28567374 | ||
Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene | Q29616540 | ||
Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury | Q33822590 | ||
Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods | Q33920115 | ||
TGFbeta1 in liver fibrosis: time to change paradigms? | Q34322705 | ||
Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist | Q34466845 | ||
Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review | Q34568687 | ||
Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases | Q35201617 | ||
UV irradiation activates JNK and increases alphaI(I) collagen gene expression in rat hepatic stellate cells | Q38330108 | ||
TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence | Q38341183 | ||
Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma | Q40907616 | ||
1,25-Dihydroxyvitamin D(3) stimulates activator protein-1-dependent Caco-2 cell differentiation | Q40914117 | ||
Expression of connective tissue growth factor in experimental rat and human liver fibrosis | Q40926848 | ||
From receptor to nucleus: the Smad pathway | Q41600955 | ||
Peroxisome proliferator-activated receptors and hepatic stellate cell activation | Q41758990 | ||
Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro | Q42808663 | ||
The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression | Q43002494 | ||
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. | Q44021747 | ||
Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth | Q44378715 | ||
Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells | Q44710999 | ||
Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells | Q44939104 | ||
Hepatic fibrosis as wound repair: a progress report | Q45111395 | ||
Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor | Q46818402 | ||
TGF-beta isoforms in alcoholic liver disease | Q47866440 | ||
Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats | Q58215294 | ||
P433 | issue | 1 | |
P921 | main subject | curcumin | Q312266 |
P304 | page(s) | G113-23 | |
P577 | publication date | 2006-09-07 | |
P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
P1476 | title | Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells | |
P478 | volume | 292 |
Q36743890 | A Novel Mechanism of PPARgamma Regulation of TGFbeta1: Implication in Cancer Biology |
Q37353099 | Advances in antifibrotic therapy |
Q36234375 | Ameliorative Effect of Curcumin-Encapsulated Hyaluronic Acid-PLA Nanoparticles on Thioacetamide-Induced Murine Hepatic Fibrosis |
Q33483669 | An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules |
Q33767832 | Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in Vivo |
Q40288159 | Curcumin Suppress Cardiac Fibroblasts Activities by Regulating Proliferation, Migration, and the Extracellular Matrix |
Q34011505 | Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells |
Q37456073 | Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress |
Q35543565 | Curcumin augments lung maturation, preventing neonatal lung injury by inhibiting TGF-β signaling |
Q28565783 | Curcumin eliminates leptin's effects on hepatic stellate cell activation via interrupting leptin signaling |
Q37438687 | Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1. |
Q34409300 | Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling |
Q37130129 | Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation |
Q51712676 | Curcumin inhibits aerobic glycolysis in hepatic stellate cells associated with activation of adenosine monophosphate-activated protein kinase. |
Q34672530 | Curcumin inhibits cobalt chloride-induced epithelial-to-mesenchymal transition associated with interference with TGF-β/Smad signaling in hepatocytes |
Q33840489 | Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury |
Q36252773 | Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress |
Q37482957 | Curcumin inhibits srebp-2 expression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1 |
Q34613675 | Curcumin limits the fibrogenic evolution of experimental steatohepatitis. |
Q28486257 | Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome |
Q37475664 | Curcumin protects the developing lung against long-term hyperoxic injury |
Q40979935 | Curcumin regulates cell fate and metabolism by inhibiting hedgehog signaling in hepatic stellate cells |
Q41919315 | Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells |
Q90461433 | Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells |
Q28554730 | Diamond Nanoparticles Modify Curcumin Activity: In Vitro Studies on Cancer and Normal Cells and In Ovo Studies on Chicken Embryo Model |
Q29616840 | Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver |
Q35601455 | Hypoxia induces downregulation of PPAR-γ in isolated pulmonary arterial smooth muscle cells and in rat lung via transforming growth factor-β signaling |
Q47109594 | Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis |
Q30369750 | Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells |
Q34665258 | Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model |
Q53294916 | Methylated chrysin, a dimethoxy flavone, partially suppresses the development of liver preneoplastic lesions induced by N-Nitrosodiethylamine in rats |
Q60914565 | Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1: Study Protocol for a Multicenter Clinical Trial |
Q36449677 | Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases |
Q53767135 | New mechanism in the modulation of carbon tetrachloride hepatotoxicity in rats using different natural antioxidants. |
Q34512881 | Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages |
Q94569750 | PPARG Drives Molecular Networks as an Inhibitor for the Pathologic Development and Progression of Lung Adenocarcinoma |
Q35458969 | PPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling. |
Q33745028 | PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis |
Q21284970 | Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection |
Q55091434 | Peroxisome proliferator-activated receptor-γ and its related pathway in bone marrow mesenchymal stem cell differentiation co-cultured with mechanically stretched ligament fibroblasts. |
Q38018841 | Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside |
Q46255340 | Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice |
Q36093802 | Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis |
Q37071874 | Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma |
Q91897242 | TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts |
Q42117396 | TGFβ1 Controls PPARγ Expression, Transcriptional Potential, and Activity, in Part, through Smad3 Signaling in Murine Lung Fibroblasts |
Q93198763 | The role and function of PPARγ in bladder cancer |
Q89590328 | Therapeutic potential of PPARγ natural agonists in liver diseases |
Q38720663 | Transforming growth factor β suppresses peroxisome proliferator-activated receptor γ expression via both SMAD binding and novel TGF-β inhibitory elements. |
Search more.